SLC9A9 and esophageal squamous cell carcinoma: We examined the expression of NHE9 in ten ESCC cell lines (Figure S1), and we selected Eca109 and KYSE30, which have relatively low levels of intrinsic NHE9, to establish stable overexpression lines (Eca109/NHE9 and KYSE30/NHE9).